“Immune Evasion and Resistance in Cancer Progression: Overcoming Checkpoint Inhibition Challenges with Personalized Immunotherapy Guided by PD-L1 Expression”, J. Anal. Oncol., vol. 14, pp. 49–61, Oct. 2025, doi: 10.30683/1927-7229.2025.14.09.